Figure 1.
Flow diagram of patients included in the study from AML17 and AML19. CR1 alloSCT, allogeneic stem cell transplantation in first complete remission.

Flow diagram of patients included in the study from AML17 and AML19. CR1 alloSCT, allogeneic stem cell transplantation in first complete remission.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal